Skip to main content
spacbrain

Pear Therapeutics

Closed (deSPAC)

Health Care · prescription digital therapeutics

What it is
A private company in health care preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with Thimble Point Acquisition Corp. (THMA) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

What the company says about itself

Web research — not audited
What our web check found

[WEB-INTEL 2026-08-26] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Pear Therapeutics to go public in roughly $1.6 billion SPAC deal" [https://www.wsj.com/articles/pear-therapeutics-to-go-public-in-roughly-1-6-billion-spac-deal-11624359600] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Pear Therapeutics to Become a Public Company Through $1.6 Billion Business Combination with Thimble Point Acquisition Corp." [https://www.goodwinlaw.com/en/news-and-events/news/2021/06/06_22-pear-therapeutics-spac-deal]

Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Pear Therapeutics is merging with Thimble Point Acquisition Corp. (THMA) currently marked Closed (deSPAC).

Headline equity value—

How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Pear Therapeutics going public?

Pear Therapeutics has an approved merger with the SPAC Thimble Point Acquisition Corp. (THMA). Deal status: Closed (deSPAC).

Does Pear Therapeutics have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals